Concepedia

Bongani Ngcobo

BN

Statistics

Publications

7

Citations

383

H-Index

7

Active since

2015

Affiliations

University of KwaZulu-Natal(Current)

Johns Hopkins Medicine

Johns Hopkins University

Howard Hughes Medical Institute

University of California, San Francisco

Bongani Ngcobo is an author at University of KwaZulu-Natal specializing in mycobacterium tuberculosis infection, tuberculosis pharmacotherapy, and pharmacology.

Publications per year

2015–2019

7

Publications

7

Pharmacokinetics and Pharmacodynamics of Clofazimine in a Mouse Model of Tuberculosis

Rosemary V. Swanson, John Adamson, Chivonne Moodley et al. · Antimicrobial Agents and Chemotherapy · 2015 · 103 citations · Full text

, , +12

Compromised Metabolic Reprogramming Is an Early Indicator of CD8+ T Cell Dysfunction during Chronic Mycobacterium tuberculosis Infection

Shannon Russell, Dirk A. Lamprecht, Tawanda Mandizvo et al. · Cell Reports · 2019 · 95 citations · Full text

, , +17

Clofazimine has delayed antimicrobial activity against<i>Mycobacterium tuberculosis</i>both<i>in vitro</i>and<i>in vivo</i>

Nicole C. Ammerman, Rosemary V. Swanson, Asa Tapley et al. · Journal of Antimicrobial Chemotherapy · 2016 · 58 citations · Full text

, , +12

Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis

Nicole C. Ammerman, Rosemary V. Swanson, Elaine M. Bautista et al. · Antimicrobial Agents and Chemotherapy · 2018 · 50 citations · Full text

, , +16

Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy

Rosemary V. Swanson, Nicole C. Ammerman, Bongani Ngcobo et al. · Antimicrobial Agents and Chemotherapy · 2016 · 33 citations · Full text

, , +17

1–5 of 7